glp-1 news today 2025 ISPOR 2025: Exploring reasons for discontinuation Many adults stop GLP-1 therapy

The deals are among the most politically significant announcements to date in the Trump administration's efforts to rein in high U.S

Online health and wellness company Hims & Hers posted a $92 million loss in the first quarter as it shifts its business from selling compounded weight loss drugs to branded GLP-1 medications.

Important conclusions drawn from recent meta-analyses involving over 300,000 patients report that while the retained gastric contents are significantly increased (fivefold to tenfold increase

cities most obsessed with GLP-1s and how injectables are reshaping body image and weight loss culture.

Semaglutide helps to reduce appetite by making patients feel fuller, faster. For patient safety and order security, we may request proof of identification as a one-time verification before processing your request for this medication.